101 related articles for article (PubMed ID: 18855573)
41. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
42. Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines.
Shim SH; Sung MW; Park SW; Heo DS
Int J Mol Med; 2009 Jun; 23(6):805-10. PubMed ID: 19424608
[TBL] [Abstract][Full Text] [Related]
43. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X
Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525
[TBL] [Abstract][Full Text] [Related]
44. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
Zhao W; Zhang T; Qu B; Wu X; Zhu X; Meng F; Gu Y; Shu Y; Shen Y; Sun Y; Xu Q
Anticancer Drugs; 2011 Jan; 22(1):79-88. PubMed ID: 20881478
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality.
Hui L; Yao Y; Wang S; Yu Y; Dong N; Li H; Sheng Z
J Trauma; 2009 Mar; 66(3):859-65. PubMed ID: 19276765
[TBL] [Abstract][Full Text] [Related]
46. Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation.
Wen SH; Li Y; Li C; Xia ZQ; Liu WF; Zhang XY; Lei WL; Huang WQ; Liu KX
Shock; 2012 Oct; 38(4):411-9. PubMed ID: 22777122
[TBL] [Abstract][Full Text] [Related]
47. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
[TBL] [Abstract][Full Text] [Related]
48. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
49. Olanzapine increases RGS7 protein expression via stimulation of the Janus tyrosine kinase-signal transducer and activator of transcription signaling cascade.
Singh RK; Shi J; Zemaitaitis BW; Muma NA
J Pharmacol Exp Ther; 2007 Jul; 322(1):133-40. PubMed ID: 17392403
[TBL] [Abstract][Full Text] [Related]
50. Role of STAT3 in ischemic preconditioning.
Hattori R; Maulik N; Otani H; Zhu L; Cordis G; Engelman RM; Siddiqui MA; Das DK
J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838
[TBL] [Abstract][Full Text] [Related]
51. Janus kinase 2: a critical target in chronic myelogenous leukemia.
Samanta AK; Lin H; Sun T; Kantarjian H; Arlinghaus RB
Cancer Res; 2006 Jul; 66(13):6468-72. PubMed ID: 16818614
[TBL] [Abstract][Full Text] [Related]
52. [Inhibitory effect of AG490 on invasion and metastasis of human pancreatic cancer cells in vitro].
Huang C; Qiu ZJ; Cao J; Huang KJ; Zhang F; Jiang T; Zhu L; Liu J
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):890-3. PubMed ID: 17533737
[TBL] [Abstract][Full Text] [Related]
53. AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation.
Fernández-Sánchez R; Berzal S; Sánchez-Niño MD; Neria F; Gonçalves S; Calabia O; Tejedor A; Calzada MJ; Caramelo C; Deudero JJ; Ortiz A
Curr Med Chem; 2012; 19(23):4014-23. PubMed ID: 22709000
[TBL] [Abstract][Full Text] [Related]
54. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
55. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells.
Park JS; Lee J; Lim MA; Kim EK; Kim SM; Ryu JG; Lee JH; Kwok SK; Park KS; Kim HY; Park SH; Cho ML
J Immunol; 2014 May; 192(9):4417-24. PubMed ID: 24688026
[TBL] [Abstract][Full Text] [Related]
56. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
[TBL] [Abstract][Full Text] [Related]
57. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
Abbaspour Babaei M; Kamalidehghan B; Saleem M; Huri HZ; Ahmadipour F
Drug Des Devel Ther; 2016; 10():2443-59. PubMed ID: 27536065
[TBL] [Abstract][Full Text] [Related]
58. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
59. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma].
Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214
[TBL] [Abstract][Full Text] [Related]
60. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]